NCT04703920 |
Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer |
NCT05457842 |
A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery |
NCT05394259 |
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer |
NCT04930783 |
NeoVax + CDX-301 and Nivolumab in Melanoma |
NCT05061017 |
Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC) |
NCT03929029 |
Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma |
NCT04117087 |
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer |
NCT05057715 |
huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer |
NCT05034536 |
Pembrolizumab + Infliximab for Metastatic Melanoma |
NCT03104439 |
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer |
NCT01638676 |
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients |
NCT04598009 |
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma |
NCT05356117 |
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial |
NCT02870244 |
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes |
NCT04315233 |
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics |
NCT03454035 |
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors |
NCT04024878 |
NeoVax With Nivolumab in Patients With Ovarian Cancer |
NCT04996823 |
Axitinib + Ipilimumab in Advanced Melanoma |
NCT05523440 |
Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation |
NCT04611568 |
War on Melanoma™ Public Health & Education Campaign |
NCT04339140 |
Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer |
NCT05308901 |
Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma |
NCT02621021 |
A Prospective Randomized and Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab |
NCT04971499 |
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma |
NCT05130177 |
Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma |
NCT04581382 |
Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma |
NCT03950635 |
Dietary Intervention in Patients With a History of Melanoma |
NCT03311308 |
A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma |
NCT04570553 |
Use of an Intrauterine Manipulator and Its Correlation With Positive Peritoneal Cytology in Early Stage Endometrial Cancers |
NCT03757689 |
Neoadjuvant PD-1 Blockade in Patients With Stage IIB/C Melanoma |
NCT04464759 |
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma |
NCT04930991 |
High Dose Omeprazole in Patients With Pancreatic Cancer |
NCT04526730 |
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients |
NCT04020809 |
Neoadjuvant Atezolizumab in Cutaneous Melanoma |
NCT05272462 |
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer |
NCT03935256 |
Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer |
NCT05384496 |
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma |
NCT03743766 |
Nivolumab, BMS-936558 in Combination With Relatlimab, BMS-986016 in Patients With Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting |
NCT05640193 |
Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Patients With Asymptomatic Melanoma Brain Metastases |
NCT01972919 |
Magnetic Resonance (MR) Guided, Dose-Escalated Radiation Therapy (RT) + Chemotherapy in Pancreatic Cancer |
NCT05089370 |
Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma |
NCT03842943 |
Neoadjuvant Combination Immunotherapy for Stage III Melanoma |
NCT05695898 |
XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) in Treating Melanoma Prior Immune Checkpoint Inhibitor Therapy |
NCT05029154 |
Exercise Preconditioning in Ovarian Cancer |
NCT04493203 |
Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma |
NCT04688658 |
Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma |
NCT04513028 |
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma |
NCT04048278 |
Lidocaine Infusion in Pancreatic Cancer |
NCT05546827 |
PRISM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal Melanoma |
NCT03925350 |
Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation |
NCT05047926 |
Prehabilitation for Advanced Ovarian Cancer Patients |
NCT03957551 |
Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma |
NCT02143050 |
Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients |
NCT05438927 |
Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer |
NCT05524935 |
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma |
NCT05675059 |
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients |
NCT03322995 |
Adaptive Modification of Neoadjuvant Therapy Based on Clinical Response in Patients With Localized Pancreatic Cancer |
NCT05077280 |
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma |
NCT04476537 |
RNA Precision Oncology in Advanced Pancreatic Cancer |
NCT05415917 |
Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy |
NCT05764720 |
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach |
NCT05200143 |
Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma |
NCT05483075 |
Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer |
NCT04318717 |
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma |
NCT04187833 |
Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes |
NCT05704647 |
Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases |
NCT04970368 |
Comparison of Nodal Staging in Endometrial Cancer |
NCT03492164 |
In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer |
NCT05498792 |
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma |
NCT03256201 |
Exercise and Nutrition to Improve Pancreatic Cancer Outcomes |
NCT05170334 |
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma |
NCT05360732 |
Redefining FOLFIORINOX in Older Pancreatic Cancer Patients |
NCT04927013 |
Connecting Families to Overcome Ovarian Cancer |
NCT04820179 |
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer |
NCT04783467 |
Time Restricted Eating (TRE) Among Endometrial Cancer Patients |
NCT04683653 |
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer |
NCT03287271 |
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK |
NCT04458402 |
Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer |
NCT04473833 |
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer |
NCT05634525 |
Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients |
NCT04844970 |
Anamorelin Study for Advanced Pancreatic Cancer |
NCT04720417 |
Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma |
NCT05549297 |
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) |
NCT05648604 |
Mentored Community Gardening for Melanoma Survivors |
NCT04386993 |
De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer |
NCT04427306 |
Neoadjuvant T-VEC in High Risk Early Melanoma |
NCT04608409 |
Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer |
NCT05316129 |
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer |
NCT05467670 |
Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer |
NCT05123807 |
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) |
NCT03385486 |
Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors |
NCT05098210 |
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma or Hormone Receptor Positive Her2 Negative Metastatic Refractory Breast Cancer |
NCT03832361 |
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer |
NCT02672098 |
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer |
NCT05229588 |
Lurbinectedin in Patients With Advanced Pancreatic Cancer With DNA Repair Mutations |
NCT03467516 |
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma |
NCT03617328 |
Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma |
NCT03323944 |
CAR T Cell Immunotherapy for Pancreatic Cancer |
NCT05715216 |
EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer |
NCT02128100 |
Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer |
NCT04928508 |
Advanced or Recurrent Ovarian, Cervical, and Endometrial Cancer Treated With SHetA2 |
NCT02340117 |
Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer |
NCT04633902 |
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation |
NCT03783325 |
Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma |
NCT03743298 |
Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma |
NCT03646617 |
Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma |
NCT05470283 |
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma |
NCT05496686 |
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma |
NCT03991130 |
High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma |
NCT04390880 |
18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer |
NCT04741997 |
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma |
NCT05189457 |
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer |
NCT04562129 |
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients |
NCT05586360 |
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer |
NCT03955978 |
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer |
NCT02331134 |
Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer |
NCT03232164 |
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer |
NCT03734692 |
Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer |
NCT04665947 |
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer |
NCT05004025 |
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma |
NCT04364230 |
Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) |
NCT04457089 |
Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer |
NCT05056896 |
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension |
NCT03223779 |
Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer |
NCT04082962 |
Dexamethasone Implant for Retinal Detachment in Uveal Melanoma |
NCT03694834 |
Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer |
NCT04588025 |
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response |
NCT04984343 |
Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer |
NCT05761561 |
Trial of Exercise and Lifestyle in Women With Ovarian Cancer |
NCT03541928 |
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery |
NCT05727904 |
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. |
NCT05526248 |
A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide |
NCT05068752 |
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer |
NCT03769766 |
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance |
NCT05417386 |
FOLFIRINOX + NIS793 in Pancreatic Cancer |
NCT03674814 |
Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer |
NCT04346225 |
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer |
NCT05026983 |
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases |
NCT02705196 |
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer |
NCT05470036 |
Improving Germline Testing in At-Risk Patients With Prostate Cancer |
NCT05826470 |
Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging |
NCT05141643 |
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer |
NCT04700332 |
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer |
NCT02282137 |
68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer |
NCT05373823 |
MySmartSkin Renewal |
NCT03863457 |
[18F] F-GLN by PET/CT in Breast Cancer |
NCT02207465 |
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer |
NCT05013216 |
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer |
NCT05111353 |
Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery |
NCT05304962 |
First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer |
NCT03596073 |
Topical Calcipotriene Treatment for Breast Cancer Immunoprevention |
NCT03951831 |
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer |
NCT04360330 |
SABER Study for Selected Early Stage Breast Cancer |
NCT03932409 |
Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer |
NCT02382549 |
A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib |
NCT05692323 |
A Supervised Prehabilitation Program for Patients With Pancreatic Cancer |
NCT05393713 |
Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for the Treatment of In-Transit Melanoma, The Sofusa-2 Study |
NCT04401995 |
Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab |
NCT02926729 |
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy |
NCT04536077 |
Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients |
NCT03861975 |
Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening |
NCT05482074 |
Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2 |
NCT05497778 |
A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer. |
NCT04903119 |
Nilotinib Plus Dabrafenib/Trametinib in Metastatic Melanoma |
NCT05764005 |
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study |
NCT04019964 |
Nivolumab in Biochemically Recurrent dMMR Prostate Cancer |
NCT05318131 |
Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer |
NCT05628883 |
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma |
NCT05683691 |
Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer |
NCT05504707 |
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer |
NCT04670068 |
Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian |
NCT05743036 |
ZN-c3 in Adult Participants With Metastatic Colorectal Cancer |
NCT03652428 |
Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC) |
NCT05311527 |
UroLift System With SAbR for Prostate Cancer and BPH |
NCT04981223 |
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging |
NCT04743999 |
Evaluation of Quality of Life Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma |
NCT05804318 |
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer |
NCT05454488 |
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer |
NCT05345444 |
Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) |
NCT05477823 |
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer |
NCT04116775 |
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. |
NCT05375539 |
AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients |
NCT05099679 |
Pilot Study for Optimizing Mental Wellbeing & Heart Health for Black Patients w/ Prostate Cancer |
NCT04502602 |
Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer |
NCT04635059 |
Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer |
NCT04842890 |
Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer |
NCT05679388 |
A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients |
NCT03765983 |
GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases |
NCT05751941 |
Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer |
NCT04552509 |
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer |
NCT05074290 |
Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients |
NCT04349501 |
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI) |
NCT04705038 |
Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments |
NCT04167969 |
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer |
NCT03392181 |
PET/MRI for the Staging of Newly Diagnosed Prostate Cancer |
NCT03665922 |
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer |
NCT05224869 |
Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer |
NCT03275857 |
Cisplatin in Castration Resistant Prostate Cancer |
NCT03971591 |
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors |
NCT05608694 |
MRI Screening in Men at High Risk of Developing Prostate Cancer |
NCT04989946 |
Androgen Deprivation, With or Without pTVG-AR, and With or Without Nivolumab, in Patients With Newly Diagnosed, High-Risk Prostate Cancer |
NCT04298983 |
Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer |
NCT03999151 |
Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II) |
NCT04651452 |
Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors |
NCT04158635 |
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer |
NCT03585660 |
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy |
NCT03315871 |
Combination Immunotherapy in Biochemically Recurrent Prostate Cancer |
NCT05014776 |
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer |
NCT02016248 |
Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer |
NCT04147806 |
A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer |
NCT05628363 |
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer |
NCT03734653 |
Testosterone Therapy in Castration Resistant Prostate Cancer |
NCT05051631 |
BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity |
NCT03663218 |
PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT) |
NCT03089203 |
CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer |
NCT04402151 |
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer |
NCT02933255 |
PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer |
NCT04243941 |
PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer |
NCT03753243 |
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer |
NCT05085548 |
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies |
NCT03763838 |
Acupressure for Fatigue in Ovarian Cancer Survivors |
NCT05011188 |
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer |
NCT04422132 |
Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks |
NCT04132505 |
Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer |
NCT04883814 |
18F-fluoroestradiol (FES) PET/CT for Breast Cancer |
NCT03564782 |
Examining Bioactivity of PVSRIPO in Invasive Breast Cancer |
NCT02600156 |
Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors |
NCT03495427 |
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores |
NCT01607008 |
MRI for Assessing Prostate Cancer Response |
NCT05800665 |
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer |
NCT03761706 |
Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of Aging |
NCT02526368 |
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer |
NCT03087903 |
A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA |
NCT05263492 |
Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer |
NCT02946996 |
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy |
NCT05156905 |
Study of Docetaxel Combined With Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer |
NCT05396872 |
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer |
NCT03965481 |
PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer |
NCT04786600 |
A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial |
NCT04270149 |
Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer |
NCT05327452 |
Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study |
NCT04452357 |
Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer |
NCT02515513 |
The Role of Muscle Cachexia in Pancreatic Cancer |
NCT00588185 |
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer |
NCT05025735 |
Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer |
NCT05378464 |
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer |
NCT04748380 |
Shared Decision-making and Colorectal Cancer Screening |
NCT02564848 |
Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65 |
NCT03668431 |
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer |
NCT04450264 |
Increasing African Immigrant Women's Participation in Breast Cancer Screening |
NCT04728633 |
Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases |
NCT04692675 |
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer |
NCT03742245 |
Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer |
NCT04967196 |
Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic Melanoma |
NCT05343013 |
TAS-102 in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy |
NCT05723107 |
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) |
NCT04336397 |
Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People |
NCT03694756 |
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer |
NCT02420977 |
Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer |
NCT00734838 |
Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy |
NCT04940442 |
Outreach and Choice in Colorectal Cancer Screening |
NCT05077098 |
Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer |
NCT03321188 |
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients |
NCT05052723 |
Cabozantinib and Pembrolizumab in Metastatic Pancreas |
NCT05558956 |
Total Body PET-CT Imaging of Prostate Cancer Using Illuccix |
NCT02040610 |
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer |
NCT05350501 |
EO2040 in Combination With Nivolumab, for Treatment of Patients With Minimal Residual Disease of Colorectal Cancer |
NCT04768426 |
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer |
NCT04039230 |
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. |
NCT04997096 |
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy |
NCT05092763 |
Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer |
NCT05446129 |
A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in Surgery |
NCT05607095 |
Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Patients With Metastatic Uveal Melanoma |
NCT05464667 |
Preoperative Irradiation for Stage I Breast Cancer |
NCT03553602 |
BEACON: HDR Brachytherapy, EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy |
NCT05113485 |
UCLA Breast Cancer Survivor Health Promotion Research Study |
NCT04965064 |
Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling |
NCT05327465 |
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy |
NCT05000502 |
Exercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved Populations |
NCT05334732 |
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters) |
NCT05625659 |
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts |
NCT03860987 |
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer |
NCT05483283 |
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care |
NCT05623488 |
CAR T Cells in Mesothelin-Expressing Breast Cancer |
NCT05444231 |
An Online Research Study: BrainHealth in Breast Cancer Survivors |
NCT04013568 |
Exercise Post-Diagnosis of Breast Cancer |
NCT04914663 |
All-extremity Exercise During Breast Cancer Chemotherapy |
NCT04754191 |
Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT03643861 |
RAD 1802: Pilot Trial of Dose Adapted Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI) |
NCT05609435 |
Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer |
NCT05704842 |
Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy |
NCT05219500 |
Targeted Alpha Therapy With 225Actinium-PSMA-I&T of Castration-resISTant Prostate Cancer (TATCIST). |
NCT04109729 |
Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer |
NCT05130840 |
Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer |
NCT05615753 |
Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer Survivors |
NCT05424783 |
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC) |
NCT04756765 |
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer |
NCT05331638 |
Prostate Cancer Genius App Education and Home-based PSA Screening for African American Men |
NCT04206319 |
Radium-223 in Biochemically Recurrent Prostate Cancer |
NCT05140252 |
Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid |
NCT05183126 |
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Breast Cancer |
NCT05675579 |
A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC) |
NCT04141995 |
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer |
NCT05636943 |
Couples' QOL in Metastatic Breast Cancer |
NCT05633979 |
Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer |
NCT03272334 |
Her2-BATS and Pembrolizumab in Metastatic Breast Cancer |
NCT05324098 |
Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy |
NCT05704933 |
Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases |
NCT04508764 |
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome |
NCT04493034 |
Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer |
NCT04594473 |
A Comprehensive Oncology Rehabilitation and Exercise (CORE) Program Among Breast Cancer Survivors |
NCT02391025 |
Gallium-68 Citrate PET Used in Prostate Cancer |
NCT04420702 |
Diffusion Basis Spectrum Imaging of the Prostate |
NCT03729115 |
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer |
NCT03324425 |
Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer |
NCT04228055 |
Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2) |
NCT03400215 |
Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer |
NCT03820141 |
Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer |
NCT02035787 |
Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients |
NCT05042687 |
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer |
NCT04040569 |
A Phase I Dose Escalation Study of Single Fraction Ablative Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer |
NCT05259410 |
Time Restricted Eating During Chemotherapy for Breast Cancer |
NCT05243641 |
Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test |
NCT04495257 |
A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC) |
NCT04354675 |
Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer |
NCT05502315 |
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer |
NCT02977468 |
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer |
NCT03712813 |
Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors |
NCT04796220 |
Focused Ultrasound and Gemcitabine in Breast Cancer |
NCT04805333 |
Phase 1 Dose Escalation of ArtemiCoffee |
NCT05176470 |
Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients |
NCT02958774 |
Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation |
NCT05880394 |
Rayzebio IIT Study of Dotatate in Breast Cancer |
NCT05528133 |
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer |
NCT04465500 |
EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer |
NCT03699995 |
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma |
NCT05169957 |
Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) |
NCT04990921 |
Study of Palliative Radiation Combined With Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer |
NCT01035112 |
Magnetic Resonance Imaging of Breast Cancer |
NCT03824145 |
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer |
NCT04243616 |
Cemiplimab in High Risk or Locally Advanced Hormone Receptor Positive HER2 Negative or Triple-Negative Breast Cancer |
NCT05588453 |
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain |
NCT05361798 |
T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy |
NCT04020575 |
Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) |
NCT04427527 |
Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia |
NCT05764395 |
Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 Inhibitors |
NCT04891068 |
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer |
NCT04523857 |
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer |
NCT05216120 |
Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas |
NCT02807597 |
Real-time Intraoperative Breast Cancer Visualization for Margin Assessment |
NCT03492671 |
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer |
NCT05305924 |
Fulvestrant+Abemaciclib With or Without Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer |
NCT05127850 |
MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer |
NCT03873818 |
Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain |
NCT03312972 |
Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy |
NCT03496805 |
Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy |
NCT03981718 |
Adipose-Induced Regeneration of Breast Skin to Treat Post-Mastectomy Radiation Injury in Breast Cancer Patients |
NCT05155033 |
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma |
NCT05036226 |
COAST Therapy in Advanced Solid Tumors and Prostate Cancer |
NCT04763174 |
An mHealth Symptom Management Intervention for Colorectal Cancer Patients (mCOPE) |
NCT05336786 |
An Imaging Agent (Perflutren Lipid Microspheres) With Ultrasound for Imaging of Prostate Cancer |
NCT03253744 |
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy |
NCT04205786 |
Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer |
NCT04332588 |
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI |
NCT04389281 |
X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma |
NCT02732171 |
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer |
NCT05654532 |
Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer |
NCT03032406 |
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer |
NCT04968964 |
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing |
NCT03933670 |
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance |
NCT04853043 |
Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer |
NCT05470699 |
RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer |
NCT05029999 |
CD40 Agonist, Flt3 Ligand, and Chemotherapy in Triple Negative Breast Cancer |
NCT04427293 |
Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC) |
NCT04095689 |
Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer |
NCT04633252 |
M9241 in Combination With Docetaxel in Adults With Metastatic Castration Sensitive and Castration Resistant Prostate Cancer |
NCT05384535 |
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort |
NCT05187832 |
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer |
NCT04450706 |
Functional Precision Oncology for Metastatic Breast Cancer |
NCT04941430 |
7T MRI Scan for the Early Detection of Melanoma Brain Metastases |
NCT05071937 |
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer |
NCT03822494 |
CyberKnife Dose Escalation Prostate Cancer Trial |
NCT04273555 |
Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging |
NCT04190056 |
Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer |
NCT04364672 |
Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Breast Cancer |
NCT05423730 |
Alcohol and Breast Cancer (ABC) Trial |
NCT03962647 |
A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer |
NCT05160597 |
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy |
NCT05067777 |
Massage for Prostate Cancer-Related Fatigue, mPROSTATE Study |
NCT03413995 |
Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations |
NCT05082025 |
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations |
NCT05130801 |
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery |
NCT03802851 |
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer |
NCT04568616 |
Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) |
NCT04337580 |
Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer |
NCT04272801 |
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer |
NCT04542135 |
Sulindac and Breast Density in Women at Risk of Developing Breast Cancer |
NCT04895761 |
Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer |
NCT02706561 |
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery |
NCT03043794 |
Study of Stereotactic Radiotherapy for Breast Cancer |
NCT05646862 |
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy |
NCT04857502 |
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer |
NCT03436745 |
The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females |
NCT03808077 |
The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer |
NCT04573231 |
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer |
NCT05676463 |
MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer |
NCT05225363 |
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer |
NCT01913106 |
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer |
NCT05233800 |
mHealth for Breast Cancer Survivors With Insomnia |
NCT03711890 |
Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer |
NCT05101564 |
Umbrella Trial Testing Integrative Subtype-Targeted Therapeutics in HR+ /HER2-Negative Breast Cancer |
NCT05700396 |
Breast Cancer Survivor Educational Intervention |
NCT05351424 |
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc |
NCT04965688 |
Systems Biology Guided Therapy for Breast Cancer Positive for Oestrogen Receptor After Aromatase Inhibitor and CDK Inhibition |
NCT04645680 |
Effect of Diet on the Immune System in Patients With Stage III-IV Melanoma Receiving Immunotherapy, DIET Study |
NCT03801369 |
Olaparib in Combination With Either Durvalumab, Selumetinib, or Capivasertib or Ceralasertib Alone in Treating Patients With Metastatic Triple Negative Breast Cancer |
NCT02070705 |
DCE MRI in Patients With Pancreatic Cancer |
NCT05077137 |
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy |
NCT03601923 |
Niraparib in Patients With Pancreatic Cancer |
NCT04837118 |
Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study |
NCT05139368 |
Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer |
NCT04748042 |
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON) |
NCT05676255 |
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project |
NCT05081193 |
Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer |
NCT04753359 |
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer |
NCT05035836 |
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) |
NCT05472792 |
Comparison of Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN) |
NCT05746897 |
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors |
NCT04697576 |
Intralesional Influenza Vaccine for the Treatment of Stage I, II, and IV Melanoma |
NCT05576896 |
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory |
NCT04134884 |
Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer |
NCT03835819 |
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) |
NCT05574686 |
Telemonitoring Hypertension and Breast Cancer |
NCT03889795 |
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors |
NCT05568680 |
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma |
NCT04634539 |
Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer |
NCT04846478 |
Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC |
NCT04458532 |
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer |
NCT04751929 |
Abemaciclib With or Without Atezolizumab for mCRPC |
NCT04594187 |
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma |
NCT05013255 |
Pioglitazone Therapy Targeting Fatigue in Breast Cancer |
NCT04090528 |
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer |
NCT05859971 |
ICG and SLN Mapping |
NCT01955460 |
Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma |
NCT05479578 |
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer |
NCT05787834 |
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer |
NCT05840211 |
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy |
NCT05447923 |
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities |
NCT05132296 |
Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer |
NCT04267796 |
Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women |
NCT05712941 |
Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer |
NCT05595499 |
Treatment of Frailty With Fisetin (TROFFi) in Breast Cancer Survivors |
NCT05022901 |
An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma |
NCT04119024 |
Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma |
NCT04469764 |
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer |
NCT05805371 |
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer |
NCT04721886 |
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer |
NCT02935205 |
Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer |
NCT04375527 |
Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma |
NCT04913064 |
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer |
NCT03719131 |
Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy |
NCT05325151 |
Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer |
NCT04251416 |
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma |
NCT05325632 |
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab |
NCT05014295 |
Patient Recall of Cancer Screening and Diagnosis |
NCT03945721 |
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients |
NCT04698564 |
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging |
NCT03821246 |
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy |
NCT05036109 |
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease |
NCT05081492 |
CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer |
NCT05010200 |
The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting. |
NCT04098081 |
1911GCCC: Galeterone or Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma |
NCT04720209 |
Taking AIM at Breast Cancer |
NCT04725903 |
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer |
NCT05011799 |
Health Education Intervention for Genetic Evaluation for Prostate Cancer Among African American Men, The Peer Genetic Study |
NCT05408260 |
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer |
NCT04256941 |
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study |
NCT04896073 |
Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP) |
NCT05200442 |
A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer |
NCT05245006 |
PET Imaging Study of 89Zr-DFO-YS5 |
NCT04824027 |
Breast Elasticity Imaging During Neoadjuvant Chemotherapy |
NCT05603910 |
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma |
NCT05391126 |
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care |
NCT05198843 |
Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body |
NCT03675893 |
Abemaciclib + Letrozole +/- Metformin in Recurrent or Persistent Endometrial Cancer |
NCT03977233 |
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer |
NCT02600949 |
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer |
NCT04821375 |
Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers |
NCT04674306 |
Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer |
NCT05305365 |
Study Assessing QBS72S For Treating Brain Metastases of Breast Cancer |
NCT05225428 |
Video Education With Result Dependent dIsclosure |
NCT03439735 |
Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC |
NCT04482244 |
RCT of CBD for Anxiety in Advanced Breast Cancer |
NCT04533763 |
Living WELL: A Web-Based Program for Ovarian Cancer Survivors |
NCT03703492 |
Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS |
NCT04866810 |
The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN) |
NCT03085043 |
Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer |
NCT02681549 |
Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer |
NCT05818683 |
A Study of JNJ-78278343 in Combination With JNJ-63723283 (Cetrelimab) for Metastatic Castration-Resistant Prostate Cancer |
NCT04620603 |
Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer |
NCT05524584 |
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer |
NCT05649072 |
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. |
NCT05497531 |
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers |
NCT05055843 |
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer |
NCT05150652 |
Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer |
NCT02884648 |
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery |
NCT05226663 |
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer |
NCT03677739 |
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families |
NCT05721248 |
STOP-HER2: Stopping Trastuzumab in HER2+ MBC |
NCT05660083 |
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) |
NCT04407611 |
Scalable Communication Modalities for Returning Genetic Research Results |
NCT04174352 |
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer |
NCT05278871 |
Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors |
NCT03955627 |
REJOIN Trial for Older Breast Cancer Survivors |
NCT04013854 |
Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab |
NCT04886986 |
225Ac-J591 Plus 177Lu-PSMA-I&T for mCRPC |
NCT05161260 |
Breathwork App for Cancer Survivors |
NCT04506567 |
Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC |
NCT05386719 |
Cardiometabolic Screening Program |
NCT03847311 |
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients |
NCT02361320 |
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer |
NCT04386057 |
LY3214996 +/- HCQ in Pancreatic Cancer |
NCT04336943 |
Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load |
NCT03407417 |
A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care |
NCT05376878 |
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis |
NCT04454528 |
BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy |
NCT03657108 |
CivaSheet With Radical Prostatectomy & Adjuvant External Beam Radiation |
NCT04493333 |
Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors |
NCT05069038 |
Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy |
NCT04887805 |
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer |
NCT03275974 |
Glutamine PET Imaging Colorectal Cancer |
NCT04203641 |
L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer |
NCT05703178 |
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia |
NCT05568472 |
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study |
NCT05034627 |
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer |
NCT04365569 |
Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program |
NCT04923542 |
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases |
NCT04724499 |
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy |
NCT04265872 |
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC |
NCT04363164 |
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression |
NCT05080946 |
Using Aspirin to Improve Immunological Features of Ovarian Tumors |
NCT05341349 |
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-100M for the Treatment of Melanoma Brain Metastases |
NCT03825289 |
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer |
NCT05289193 |
CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma |
NCT04998682 |
Prospective Evaluation of Targeted Axillary Dissection (TAD) |
NCT05764330 |
Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance |
NCT04636710 |
Refining Local-Regional Therapy for IBC |
NCT04486755 |
Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) |
NCT05256745 |
RAGE Inhibition to Decrease Therapy Cardiotoxicity in Women With Early Breast Cancer |
NCT04457232 |
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation |
NCT04116073 |
INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer |
NCT03769415 |
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA |
NCT04753879 |
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. |
NCT05168618 |
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial |
NCT03833921 |
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer |
NCT05496959 |
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study |
NCT04539808 |
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer |
NCT04983342 |
Apollo Device for Metastatic Breast Cancer (MBC) |
NCT02965755 |
Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins |
NCT02334579 |
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer |
NCT02106598 |
Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases |
NCT03727789 |
CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma |
NCT00969111 |
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy |
NCT03175432 |
Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases |
NCT05700669 |
Study To Assess Safety And Efficacy Of AsiDNA In Combination With Olaparib In Participants With Recurrent Solid Tumors |
NCT02905578 |
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) |
NCT04750941 |
Study of Copanlisib and Ketogenic Diet |
NCT04978675 |
An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer |
NCT04106856 |
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER) |
NCT04886531 |
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in Triple Positive Breast Cancers |
NCT03460067 |
Omission of Radiation in Patients With Her-2 Positive Breast Cancer |
NCT03856658 |
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases |
NCT04668976 |
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma |
NCT05447910 |
Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer |
NCT02064673 |
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy |
NCT04379414 |
YES Study - Newly Diagnosed/Metastatic Intervention |
NCT05710328 |
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial |
NCT05436808 |
Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer |
NCT02476786 |
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score |
NCT04587128 |
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC |
NCT04356729 |
A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma |
NCT05694559 |
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics |
NCT03285412 |
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer |
NCT05546411 |
A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer |
NCT01802346 |
Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer |
NCT05673200 |
Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer |
NCT05505045 |
Metacognitive Strategy Training in Cancer-related Cognitive Impairment |
NCT04716725 |
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer |
NCT05036681 |
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma |
NCT05691504 |
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers |
NCT04305834 |
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. |
NCT05464082 |
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC |
NCT04926181 |
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer |
NCT04263025 |
AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft |
NCT04870515 |
Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study |
NCT04734730 |
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer |
NCT04614194 |
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib |
NCT04777071 |
An Investigational Scan (68Ga-PSMA-11 PET/CT) for the Imaging of Prostate Cancer |
NCT04120246 |
Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer |
NCT05773703 |
Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer |
NCT05219695 |
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI) |
NCT05523154 |
Nanopore Sequencing for Detecting Bacteria in Bile and Preventing Surgical Site Infections in Patients Undergoing Surgery for Benign or Malignant Pancreatic Tumors |
NCT03873805 |
PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer |
NCT05054296 |
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring |
NCT04955743 |
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma |
NCT05438563 |
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Intermediate Grade Prostate Cancer |
NCT04973930 |
Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer |
NCT04088708 |
Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors |
NCT04521764 |
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer |
NCT04727632 |
[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial |
NCT02871726 |
Transrectal Ultrasound Robot-Assisted Prostate Biopsy |
NCT05560685 |
SMART-ER: Symptom Monitoring With Patient-reported Outcomes |
NCT04215029 |
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans |
NCT05498272 |
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1/2 Gene Alterations |
NCT03725761 |
IMMU-132 in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy |
NCT04947917 |
Axillary Lymph Node Tattoo Marking Study |
NCT04985565 |
Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer |
NCT03987217 |
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients |
NCT04493060 |
Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer |
NCT03543189 |
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy |
NCT02538484 |
Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects |
NCT05582759 |
Sleep Hygiene Education, ReadiWatchTM Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia Effect, on Symptom Relief for Men With Prostate Cancer Receiving Androgen Deprivation Therapy |
NCT05471414 |
Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer |
NCT05121545 |
Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors |
NCT01985828 |
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer |
NCT04995978 |
Insulin Resistance and Androgen Deprivation Therapy |
NCT05746325 |
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast Cancer |
NCT03033225 |
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study |
NCT04940299 |
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma |
NCT04947254 |
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer |
NCT03685331 |
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer |
NCT03269526 |
BATs Treatment for Pancreatic Cancer, Phase Ib/II |
NCT01984138 |
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy |
NCT04583891 |
Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design |
NCT04477343 |
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma |
NCT05571839 |
A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors |
NCT04233385 |
Myofascial Massage for Pain and Immobility Following Breast Cancer Surgery |
NCT03546686 |
Peri-Operative Ipilimumab+Nivolumab and Cryoablation in Women With Triple-negative Breast Cancer |
NCT03772834 |
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer |
NCT04648904 |
Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer |
NCT04348747 |
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer |
NCT03608631 |
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation |
NCT05243862 |
Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. |
NCT03995082 |
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey |
NCT05787587 |
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors |
NCT05704283 |
3D Ultrasound for the Imaging of Axillary Lymph Nodes in Patients With Breast Cancer |
NCT05340673 |
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer |
NCT04986579 |
Scalp Cooling in MBC |
NCT05409664 |
Moving Forward Together 4 |
NCT03580499 |
Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy |
NCT03449108 |
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas |
NCT05452681 |
A QoL Intervention for Young African American Breast Cancer Survivors |
NCT04871139 |
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer |
NCT05456373 |
Intraoperative Use of ClearEdge Device in Breast Conserving Surgery |
NCT05230810 |
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer. |
NCT03983577 |
Efficacy of Point Of Service Testing in MBC |
NCT05591547 |
Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen for patIents With Favorable Risk breaSt cancEr |
NCT04049214 |
Perioperative Mindfulness Proposal |
NCT04030507 |
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer |
NCT04731844 |
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer |
NCT05422794 |
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer |
NCT05176756 |
RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR) |
NCT05155046 |
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy |
NCT04318028 |
An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer |
NCT05114798 |
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers |
NCT05674578 |
Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors |
NCT05025059 |
Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer |
NCT04656678 |
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer |
NCT03990610 |
An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast Reconstruction |
NCT03844750 |
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases |
NCT05243056 |
A Quality of Life Intervention (Y-AMBIENT) for Young African American With Stage I-III Breast Cancer |
NCT03999515 |
Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer |
NCT04692818 |
3D Ultrasound Breast Imaging |
NCT05419479 |
Switch Maintenance in Pancreatic |
NCT05113537 |
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer |
NCT04791384 |
Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer |
NCT03955991 |
VSMART (Video-Conference Stress Management and Relaxation Training for Older Women With Breast Cancer) |
NCT03366155 |
Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver |
NCT04290897 |
Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors |
NCT05678322 |
Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy |
NCT05525806 |
Clinical Utility Study for MyProstateScore+ |
NCT04754412 |
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study |
NCT05049746 |
Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy |
NCT05381103 |
PSMA-PET to Guide Prostatectomy |
NCT04717050 |
Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity |
NCT05043012 |
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study) |
NCT05038332 |
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT]) |
NCT04982536 |
Assessment of VMCore Biopsy Versus Standard of Care Biopsy |
NCT04867603 |
Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions |
NCT04849871 |
Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma |
NCT04394676 |
The Impact of Low Pressure Pneumo in RARP II |
NCT03785288 |
Vaginal Cuff Brachytherapy Fractionation Study |
NCT03575832 |
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners |
NCT04249622 |
Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer |
NCT05388877 |
E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma |
NCT05298605 |
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women |
NCT05045066 |
Differences in Immunological Effects of Vitamin D Replacement Among African American Prostate Cancer Patients With Localized Versus Metastatic Disease |
NCT05364450 |
Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors |
NCT04030559 |
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects |
NCT04022772 |
Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer |
NCT04207359 |
Effects of Creatine Supplementation in Breast Cancer Survivors |
NCT05095207 |
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer |
NCT02307058 |
Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy |
NCT05677802 |
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer |
NCT05411094 |
Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer |
NCT05617755 |
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer |
NCT05037500 |
Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer |
NCT04454086 |
Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors |
NCT04445844 |
INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study |
NCT05631873 |
Colonoscopy Screening: Setting Epic Follow-up Times |
NCT05759949 |
First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors |
NCT04870034 |
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer |
NCT03880422 |
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors |
NCT03503344 |
Apalutamide With or Without Stereotactic Body Radiation Therapy in Treating Participants With Castration-Resistant Prostate Cancer (PILLAR) |
NCT04049695 |
Improving Cognition After Cancer |
NCT04524702 |
Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer |
NCT04890054 |
Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC |
NCT03796559 |
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes |
NCT02754752 |
Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment |
NCT04205903 |
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer |
NCT05092477 |
Integrated Intervention for Breast Cancer Survivors With Diabetes |
NCT04715958 |
Monitoring Neoadjuvant Chemotherapy of Breast Cancer Using 3D Subharmonic Aided Pressure Estimation |
NCT04090567 |
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer |
NCT05731947 |
Evaluation of SNDX-5613 in Participants With Colorectal Cancer and Other Solid Tumors |
NCT05691465 |
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells |
NCT03424850 |
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy |
NCT04535323 |
Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer |
NCT01174121 |
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer |
NCT05319873 |
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer |
NCT03554083 |
Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma |
NCT03298945 |
Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens |
NCT04576871 |
Re-treatment 225Ac-J591 for mCRPC |
NCT05177796 |
Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer |
NCT03207529 |
Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer |
NCT04673448 |
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer |
NCT05162846 |
Methods for Increasing Genetic Testing Uptake in Michigan |
NCT04374747 |
Fruit and Vegetable Intervention in Lactating Women to Reduce Breast Cancer Risk |
NCT05473026 |
Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors |
NCT03897270 |
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects |
NCT03535727 |
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer |
NCT03824652 |
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy |
NCT04428905 |
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer |
NCT04677816 |
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients |
NCT03657069 |
Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing Mastectomy |
NCT05716542 |
Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial) |
NCT03216421 |
Intraoperative Radiation Therapy (IORT) in DCIS |
NCT04016376 |
Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction |
NCT05453630 |
Colonoscopy Outreach for Rural Communities Aim 2 |
NCT04839614 |
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia |
NCT05417308 |
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer |
NCT03698162 |
Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases |
NCT04762979 |
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer |
NCT05428007 |
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma |
NCT05245812 |
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy |
NCT04843306 |
Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients |
NCT05809752 |
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) |
NCT03844620 |
Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer |
NCT04789486 |
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer |
NCT04796818 |
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response |
NCT04484909 |
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer |
NCT03987386 |
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer |
NCT05494697 |
Ampligen Compared to No Treatment Following FOLFIRINOX in Subjects With Locally Advanced Pancreatic Adenocarcinoma |
NCT04085510 |
Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania |
NCT03572283 |
Bethanechol Prior to Pancreatic Surgery |
NCT05141513 |
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma |
NCT05823402 |
Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study) |
NCT02535078 |
Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma |
NCT04616183 |
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer |
NCT04017650 |
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer |
NCT04754425 |
Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer |
NCT03991962 |
Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma |
NCT03910387 |
Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer |
NCT03704662 |
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma |
NCT04471974 |
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
NCT05286814 |
M9241 in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer or Intrahepatic Cholangiocarcinoma |
NCT03087071 |
Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer |
NCT02558946 |
Physical Therapy for Men Undergoing Prostatectomy |
NCT04139902 |
Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma |
NCT05200559 |
T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors |
NCT05769959 |
Study of RO7515629 in Participants With HLA-G Positive Solid Tumors |
NCT04645810 |
A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence |
NCT04592237 |
Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer |
NCT02451982 |
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas |
NCT05712668 |
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors |
NCT03384836 |
Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery |
NCT04616534 |
Testing the Addition of an Anti-cancer Drug, BAY 1895344 ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors |
NCT04683315 |
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples |
NCT04951492 |
Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma |
NCT05086705 |
EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer |
NCT02689427 |
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer |
NCT04390399 |
Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer |
NCT05571293 |
Combination Immunotherapy in Colorectal Cancer |
NCT05627635 |
FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer |
NCT02946697 |
A Culturally Sensitive Social Support Intervention |
NCT03449238 |
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients |
NCT04763902 |
Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer |
NCT05608252 |
VS-6766+Abema+Fulv in Met HR+/HER- BC |
NCT04005690 |
Targeted PARP or MEK/ERK Inhibition in Patients With Pancreatic Cancer |
NCT04940286 |
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer |
NCT05565534 |
Diabetes Care for Breast Cancer Patients |
NCT03213041 |
Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer |
NCT05535192 |
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients |
NCT04722341 |
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators |
NCT04705363 |
A Sociolinguistic-enabled Web Application to Develop Precision Health Intervention for African Americans |
NCT03955510 |
Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis |
NCT04959474 |
SABR-CaRe in Early Stage Breast Cancer |
NCT05693766 |
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort |
NCT04313114 |
The PRIME-CRC Trial to Promote CRC Screening in Rural Communities |
NCT03345420 |
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer |
NCT03640208 |
Educate, Assess Risk and Overcoming Barriers to Colorectal Screening Among African Americans |
NCT05241249 |
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma |
NCT03768492 |
Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy |
NCT05038137 |
Time Restricted Eating on Cancer Risk |
NCT05557877 |
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer |
NCT04599218 |
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer |
NCT04253483 |
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer |
NCT05012176 |
An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors |
NCT05094102 |
Intraoperative Evaluation of Axillary Lymphatics |
NCT05365893 |
PHL Treatment in Pancreatic Cancer |
NCT04407247 |
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma |
NCT03484299 |
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma |
NCT02598349 |
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas |
NCT05055323 |
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer |
NCT03540017 |
HIPEC After Initial CRS in Patients Who Have Received NACT |
NCT04485767 |
RESIST-ADT (Androgen Deprivation Therapy) |
NCT04763915 |
Improving Care After Inherited Cancer Testing |
NCT02830724 |
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers |
NCT03592888 |
DC Vaccine in Pancreatic Cancer |
NCT05683964 |
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression |
NCT03737370 |
Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer |
NCT05269160 |
Topical Dermaprazole for Radiation Dermatitis in Breast Cancer and Head and Neck Cancer Patients (TOPAZ) |
NCT04599140 |
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial |
NCT04927663 |
11C-YJH08 PET Imaging for the Detection of Glucocorticoid Receptor Expression in Patients With Metastatic Prostate Cancer |
NCT02484404 |
Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... |
NCT03796273 |
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases |
NCT03073785 |
Hypofractionated Stereotactic Body Radiation Therapy and Fluorouracil or Capecitabine With or Without Zoledronic Acid in Treating Patients With Locally Advanced Pancreatic Cancer |
NCT04837209 |
Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer |
NCT03907527 |
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
NCT04616248 |
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors |
NCT05468034 |
Exercise in Metastatic Breast Cancer: EMBody |
NCT04975217 |
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer |
NCT03885284 |
Study of Proton Therapy in Adjuvant Pancreatic Cancer |
NCT04915508 |
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy |
NCT03865875 |
Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program |
NCT05114421 |
Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients |
NCT05155501 |
Clinical Trial of Approaches to Prostate Cancer Surgery |
NCT05304936 |
HCW9218 for Advanced Pancreatic Cancer |
NCT05289830 |
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer |
NCT02452008 |
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer |
NCT05335993 |
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. |
NCT04594772 |
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma |
NCT04606914 |
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
NCT03732950 |
Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer |
NCT05077800 |
FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer |
NCT03716739 |
Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency |
NCT05010759 |
Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer |
NCT03851237 |
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy |
NCT04396808 |
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer |
NCT05645471 |
Together After Cancer |
NCT04981834 |
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer |
NCT04194554 |
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer |
NCT02095184 |
GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients |
NCT02949284 |
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery |
NCT04965311 |
Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy |
NCT04143516 |
Tissue Analysis After Thermal Ablation for Colon Cancer Liver Metastases Leading to Immediate Retreatment |
NCT05362032 |
Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate |
NCT04305145 |
Infliximab for Treatment of Ipilimumab Colitis |
NCT05795101 |
TRUDI: TDXD+Durva in HER2+/Low IBC |
NCT04646434 |
Brain and Pelvic Floor Muscle Activity of Patients Undergoing Robot-Assisted Radical Prostatectomy |
NCT05515978 |
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients |
NCT05142358 |
A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose |
NCT04444622 |
Immunotherapy for Third Line Metastatic Colorectal Cancer |
NCT03796767 |
Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer |
NCT02757859 |
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery |
NCT03701581 |
4-aminopyridine Treatment for Nerve Injury |
NCT05595213 |
Wrist Cooling for Hot Flashes Clinical Trial |
NCT03642067 |
Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer |
NCT04990609 |
A Single-arm Phase II Study to Evaluate the Safety and Efficacy of Combination Systematic Chemotherapy and Multiple Rounds of Endoscopic Ultrasound-guided Radiofrequency Ablation in Pancreatic Cancer |
NCT02124421 |
HOT: HIPEC in Ovarian Cancer as Initial Treatment |
NCT03781154 |
Predictors of Physical Activity Maintenance in Colorectal Cancer Survivors |
NCT04514692 |
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging |
NCT03008408 |
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma |
NCT05366842 |
Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care |
NCT05271318 |
Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Ovarian Cancer |
NCT05789433 |
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer |
NCT05296421 |
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer |
NCT04662879 |
Early Detection Initiative for Pancreatic Cancer |
NCT05458544 |
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application |
NCT03991741 |
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors |
NCT03507608 |
Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression |
NCT04812366 |
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer |
NCT02422641 |
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis |
NCT04234386 |
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer |
NCT05336266 |
A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma |
NCT05458674 |
A Phase II Study of the Safety, Tolerability and Antitumor Activity of Tucatinib in Combination With Eribulin and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer |
NCT04527900 |
The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach |
NCT05455658 |
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer |
NCT05098327 |
Pioglitazone and Insulin Resistance in ADT |
NCT03290677 |
Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer and Metastatic Melanoma Receiving Post-progression Immune Checkpoint Inhibitor Therapy |
NCT04906200 |
Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors |
NCT04862585 |
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel |
NCT03671044 |
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients |
NCT05868187 |
CanRestoreFunction Cancer-related Fatigue ( CRF ) |
NCT01794403 |
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer |
NCT04896320 |
Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer. |
NCT01712815 |
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer |
NCT04879940 |
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization |
NCT02891538 |
Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients |
NCT04993313 |
Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study |
NCT05039801 |
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors |
NCT03784677 |
A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors |
NCT02760030 |
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery |
NCT04329065 |
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer |
NCT05040568 |
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD) |
NCT05464810 |
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer |
NCT03789097 |
Vaccination With Flt3L, Radiation, and Poly-ICLC |
NCT05130580 |
Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction |
NCT04925817 |
3D Ultrasound Microvessel Imaging for Breast Masses |
NCT01407263 |
Trial of Modifications to Radical Prostatectomy |
NCT03419585 |
The "PC-LIGHT" Study |
NCT04849858 |
Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures |
NCT05412953 |
Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle Pain |
NCT05296512 |
Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer |
NCT05301114 |
Social Risk Factors and Discrimination in Cancer Survivorship |
NCT04294225 |
Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer |
NCT04848337 |
Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer |
NCT05368428 |
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer |
NCT04837833 |
An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma |
NCT05056077 |
Improving Nutrition and Physical Activity for Colorectal Cancer Survivors (Tools To Be Fit) |
NCT05251714 |
CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer |
NCT05677048 |
Feasibility Study: IGNITE-TX (Identifying Texans at Risk for Hereditary Cancer) Intervention |
NCT04899908 |
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases |
NCT05524428 |
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study |
NCT04514484 |
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV |
NCT04868604 |
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) |
NCT05269381 |
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study |
NCT05194735 |
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors |
NCT04009044 |
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast |
NCT03179904 |
FASN Inhibitor TVB-2640 and Trastuzumab in Combination With Paclitaxel or Endocrine Therapy for the Treatment of HER2 Positive Metastatic Breast Cancer |
NCT04946864 |
A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer |
NCT05807074 |
Impact of Topical Tranexamic Acid in Breast Reconstruction |
NCT05774678 |
Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Nanomechanical Biomarker Evaluation |
NCT05754749 |
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions |
NCT05744557 |
Vapocoolant Analgesia for Breast Lymphoscintigraphy |
NCT05731791 |
Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation |
NCT02926690 |
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer |
NCT03715959 |
Nipple Aspirate Fluid in Detecting Breast Cancer |
NCT05496829 |
IMPACT Trial: Intervention to iMProve AdherenCe Equitably |
NCT05488444 |
A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care |
NCT05428709 |
Women In Steady Exercise Research - Window of Opportunity for Exercise and Tumor Biology |
NCT05291507 |
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System |
NCT05206331 |
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study |
NCT04331041 |
Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma |
NCT04387227 |
Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
NCT05181722 |
Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic |
NCT05178927 |
UFPTI 2105-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization |
NCT04000880 |
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health |
NCT04603911 |
RCT Comparing ESPB Solutions in Breast Surgery |
NCT04534010 |
Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts |
NCT04476654 |
Improving Uptake of Genetic Cancer Risk Assessment in African American Women- Video |
NCT04348123 |
Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography |
NCT05698576 |
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer |
NCT04258280 |
Improving Genetic Counseling for BRCA+ Mothers |
NCT04225572 |
Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT) |
NCT04175639 |
mHealth Behavioral Cancer Pain Intervention for Medically Undeserved Patients |
NCT04905082 |
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics |
NCT02593175 |
Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC |
NCT03321045 |
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness |
NCT03238976 |
Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core Biopsy |
NCT04943536 |
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer |
NCT03953157 |
Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors |
NCT02317783 |
Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment |
NCT04946370 |
Maximizing Responses to Anti-PD1 Immunotherapy With PSMA-targeted Alpha Therapy in mCRPC |
NCT05585034 |
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors |
NCT04771520 |
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors |
NCT05287451 |
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study |
NCT05056844 |
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge |
NCT01492972 |
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer |
NCT04896580 |
IIT2020-20-SHIRAZIP-WALK: Nature Walks |
NCT05369000 |
Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer |
NCT03861702 |
Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: |
NCT03257670 |
Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors |
NCT04055649 |
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer |
NCT05733000 |
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors |
NCT04743934 |
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer |
NCT05597878 |
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy |
NCT03361735 |
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer |
NCT04815083 |
Fluorescence Imaging of Carcinoma During Breast Conserving Surgery |
NCT05195970 |
Walnuts and Colon Health |
NCT05316324 |
A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction |
NCT05223322 |
Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction |
NCT05314179 |
Dignity, Legacy, Advocacy, and Support for Advanced Cancer: Reimagined End of Life Care in the Black Community |
NCT04288687 |
A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects |
NCT04704505 |
Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) |
NCT04604158 |
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients |
NCT02769962 |
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer |
NCT04692831 |
Testing a New Imaging Agent to Identify Cancer |
NCT03448003 |
Comprehensive Lifestyle Change To Prevent Breast Cancer |
NCT05190978 |
Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction |
NCT05241210 |
Real-Time Feedback (RTFB) to Improve Colonoscopy |